However; despite being the earliest, most common and arguably most widely established paradigm of high penetrance cancer susceptibility, recent analyses suggest low ascertainment, with fewer than 3% of BRCA1/BRCA2 heterozygotes across Greater London identified.13 The gene discussed is BRCA1; the disease is cancer.